|
[1]de GROOTE J, DESMET VJ, GEDIGK P, et al.A classifcation of chronic hepatitis[J].Lancet, 1968, 2 (7568) :626-628.
|
|
[2]Acute and chronic hepatitis revisited.Review by an international group[J].Lancet, 1977, 2 (8044) :914-919.
|
|
[3]LUDWIG J.The nomenclature of chronic active hepatitis:An obituary[J].Gastroenterology, 1993, 105 (1) :274-278.
|
|
[4]GERBER MA.Chronic hepatitis C:The beginning of the end of a time-honored nomenclature?[J].Hepatology, 1992, 15 (4) :733-734.
|
|
[5]DESMET VJ, GERBER M, HOOFNAGLE JH, et al.Classifcation of chronic hepatitis:Diagnosis, grading and staging[J].Hepatology, 1994, 19 (6) :1513-1520.
|
|
[6]SCHEUER PJ.The nomenclature of chronic hepatitis:Time for a change[J].J Hepatol, 1995, 22 (1) :112-114.
|
|
[7]KNODELL RG, ISHAK KG, BLACK WC, et al.Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis[J].Hepatology, 1981, 1 (5) :431-435.
|
|
[8]HUBSCHER SG.Histological grading and staging in chronic hepatitis:Clinical applications and problems[J].J Hepatol, 1998, 29 (6) :1015-1022.
|
|
[9]BRUNT EM.Grading and staging the histopathological lesions of chronic hepatitis:The Knodell histology activity index and beyond[J].Hepatology, 2000, 31 (1) :241-246.
|
|
[10]DESMET VJ, KNODELL RG, ISHAK KG, et al.Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis[J].J Hepatol, 2003, 38 (4) :382-386.
|
|
[11]SCHEUER PJ.Classifcation of chronic viral hepatitis:A need for reassessment[J].J Hepatol, 1991, 13 (3) :372-374.
|
|
[12]BATTS KP, LUDWIG J.Chronic hepatitis.An update on terminology and reporting[J].Am J Surg Pathol, 1995, 19 (12) :1409-1417.
|
|
[13]ISHAK K, BAPTISTA A, BIANCHI L, et al.Histological grading and staging of chronic hepatitis[J].J Hepatol, 1995, 22 (6) :696-699.
|
|
[14]BEDOSSA P, POYNARD T.An algorithm for the grading of activity in chronic hepatitis C.The METAVIR Cooperative Study Group[J].Hepatology, 1996, 24 (2) :289-293.
|
|
[15]WANLESS IR, NAKASHIMA E, SHERMAN M.Regression of human cirrhosis:Morphologic features and the genesis of incomplete septal cirrhosis[J].Arch Pathol Lab Med, 2000, 124 (11) :1599-1607.
|
|
[16]SUN Y, ZHOU J, WANG L, et al.New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment[J].Hepatology, 2017, 65 (5) :1438-1450.
|
|
[17]BRAVO AA, SHETH SG, CHOPRA S.Liver biopsy[J].N Engl JMed, 2001, 344 (7) :495-500.
|
|
[18]FARRELL RJ, SMIDDY PF, PILKINGTON RM, et al.Guided versus blind liver biopsy for chronic hepatitis C:Clinical benefts and costs[J].J Hepatol, 1999, 30 (4) :580-587.
|
|
[19] GRANT A, NEUBERGER J.Guidelines on the use of liver biopsy in clinical practice.British Society of Gastroenterology[J].Gut, 1999, 45 (Suppl 4) :IV1-IV11.
|
|
[20]Mac SWEEN RNM, BURT AD, PORTMANN BC, et al.Pathology of the Liver[M].4th ed.New York:Churchill Livingstone, 2002:943-960.
|
|
[21]GUIDO M, RUGGE M.Liver biopsy sampling in chronic viral hepatitis[J].Semin Liver Dis, 2004, 24 (1) :89-97.
|
|
[22]WALDSTEIN SS, SZANTO PB.Accuracy of sampling by needle biopsy in diffuse liver disease[J].Arch Pathol (Chic) , 1950, 50 (3) :326-328.
|
|
[23]Mc HUTCHISON JG, GORDON SC, SCHIFF ER, et al.Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C[J].N Engl J Med, 1998, 339 (21) :1485-1492.
|
|
[24]POYNARD T, MARCELLIN P, LEE SS, et al.Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus[J].Lancet, 1998, 352 (9138) :1426-1432.
|
|
[25]SHERLOCK S, DOOLEY J.Diseases of the liver and biliary system[M].Cambridge, MA:Blackwell Science, Oxford, 1997.
|
|
[26]HOLUND B, POULSEN H, SCHLICHTING P.Reproducibility of liver biopsy diagnosis in relation to the size of the specimen[J].Scand J Gastroenterol, 1980, 15 (3) :329-335.
|
|
[27]SCHLICHTING P, HOLUND B, POULSEN H.Liver biopsy in size of specimen[J].Scand J Gastroenterol, 1983, 18 (1) :27-32.
|
|
[28]COLLOREDO G, GUIDO M, SONZOGNI A, et al.Impact of liver biopsy size on histological evaluation of chronic viral hepatitis:The smaller the sample, the milder the disease[J].J Hepatol, 2003, 39 (2) :239-244.
|
|
[29]SKRIPENOVA S, TRAINER TD, KRAWITT EL, et al.Variability of grade and stage in simultaneous paired liver biopsies in patients with hepatitis C[J].J Clin Pathol, 2007, 60 (3) :321-324.
|
|
[30]BEDOSSA P, DARGERE D, PARADIS V.Sampling variability of liver fibrosis in chronic hepatitis C[J].Hepatology, 2003, 38 (6) :1449-1457.
|
|
[31]The French METAVIR Cooperative Study Group.Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C[J].Hepatology, 1994, 20 (1 Pt 1) :15-20.
|
|
[32]THEISE ND.Liver biopsy assessment in chronic viral hepatitis:Apersonal, practical approach[J].Mod Pathol, 2007, 20 (Suppl1) :s3-s14.
|
|
[33]GOODMAN ZD.Grading and staging systems for inflammation and fbrosis in chronic liver diseases[J].J Hepatol, 2007, 47 (4) :598-607.
|
DownLoad: